Information:
Fel:
Nyckelord
Continuité du traitement médicamenteux ×
- Clinical Trial (12)
- Vaccination (6)
- Type 2 Diabetes (4)
- Quality of Life (3)
- On-Study Form (3)
- Eligibility Determination (3)
- Restless Legs Syndrome (2)
- Haemophilus influenzae type b (2)
- Influenza, Human (2)
- Influenza Vaccines (2)
- Neisseria meningitidis (2)
- Poliomyelitis (1)
- Rotavirus (1)
- Tetanus (1)
- Whooping Cough (1)
- Clinical Trial, Phase IV (1)
- Meningococcal Vaccines (1)
- Adverse event (1)
- Drug trial (1)
- Diabetes Mellitus (1)
- Diphtheria (1)
- Hepatitis B (1)
- Infection (1)
- Meningitis, Meningococcal (1)
- Neurology (1)
- Patient Compliance (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
15 Sökresultat.
Item-grupper: General Information, 1. Over the past two weeks, how bothered have you been by..., 2. Over the past two weeks, how bothered have you been by any of the following due to your diabetes medication(s)?, 3. Over the past past two weeks, how dissatisfied or satisfied have you been with the ability of your diabetes medication(s) to...., 4. Overall, over the past two weeks, how dissatisfied or satisfied have you been with...., 5. Thinking about your diabetes medication(s) over the past two weeks...., 6. Over the past two weeks, how often has taking your diabetes medication(s) as prescribed interfered with your ability to..., 7. Overall, thinking about each of the aspects of your diabetes medication(s) as mentioned above, how dissatisfied or satisfied have you been with ...., 8. Overall, based on your current experiences with your diabetes medications...
Item-grupper: General Information, 1. Over the past two weeks, how bothered have you been by..., 2. Over the past two weeks, how bothered have you been by any of the following due to your diabetes medication(s)?, 3. Over the past past two weeks, how dissatisfied or satisfied have you been with the ability of your diabetes medication(s) to...., 4. Overall, over the past two weeks, how dissatisfied or satisfied have you been with...., 5. Thinking about your diabetes medication(s) over the past two weeks...., 6. Over the past two weeks, how often has taking your diabetes medication(s) as prescribed interfered with your ability to..., 7. Overall, thinking about each of the aspects of your diabetes medication(s) as mentioned above, how dissatisfied or satisfied have you been with ...., 8. Overall, based on your current experiences with your diabetes medications...
Item-grupper: General Information, 1. Over the past two weeks, how bothered have you been by..., 2. Over the past two weeks, how bothered have you been by any of the following due to your diabetes medication(s)?, 3. Over the past past two weeks, how dissatisfied or satisfied have you been with the ability of your diabetes medication(s) to...., 4. Overall, over the past two weeks, how dissatisfied or satisfied have you been with...., 5. Thinking about your diabetes medication(s) over the past two weeks...., 6. Over the past two weeks, how often has taking your diabetes medication(s) as prescribed interfered with your ability to..., 7. Overall, thinking about each of the aspects of your diabetes medication(s) as mentioned above, how dissatisfied or satisfied have you been with ...., 8. Overall, based on your current experiences with your diabetes medications...
Item-grupper: Administrative Documentation, Pharmaceutical Preparations
Item-grupper: Administrative Documentation, Pharmaceutical Preparations
Item-grupper: Inclusion Criteria, Exclusion Criteria
Item-grupper: Administrative Documentation, Adverse Event, Symptoms, Local, Symptoms, Local, Other, Pharmaceutical Preparations, Adverse Event, General symptom, General symptom, Other
Item-grupper: Inclusion Criteria, Exclusion Criteria
Item-grupper: Administrative Documentation, Pharmaceutical Preparations
Item-grupper: Administrative documentation, Pharmaceutical Preparations
Item-grupper: Administrative documentation, Pharmaceutical Preparations
Item-grupper: Administrative documentation, Pharmaceutical Preparations